June 28, 2012: Summer School "Marine Biotechnology" - Lecture

at 12:15 in the large conference room (Großer Konferenzraum), GEOMAR, westshore building Düsternbrooker Weg 20

European Screening Port (ESP) is a contract research organization which operates across three main business areas: 

Drug Discovery – Working exclusively with academic and research institutes, ESP provides a complete drug discovery service covering all stages from target validation via small molecule screening to candidate selection

Biomarker and Translational Research – In their specialist laboratory facilities embedded in a University clinical research centre, they support biomarker discovery studies for clinical and pre-clinical research projects

Enabling Technologies – The company actively develops and benchmarks novel assay and screening technologies in partnership with the life-science industry.

http://screeningport.com/